PL1926499T3 - Zastosowanie terapeutycznie aktywnych lipidów wraz ze sposobem wytwarzania swoistych dla narządu/tkanki terapeutycznie aktywnych lipidów - Google Patents

Zastosowanie terapeutycznie aktywnych lipidów wraz ze sposobem wytwarzania swoistych dla narządu/tkanki terapeutycznie aktywnych lipidów

Info

Publication number
PL1926499T3
PL1926499T3 PL06805305T PL06805305T PL1926499T3 PL 1926499 T3 PL1926499 T3 PL 1926499T3 PL 06805305 T PL06805305 T PL 06805305T PL 06805305 T PL06805305 T PL 06805305T PL 1926499 T3 PL1926499 T3 PL 1926499T3
Authority
PL
Poland
Prior art keywords
therapeutically active
active lipids
tissue
producing organ
specific
Prior art date
Application number
PL06805305T
Other languages
English (en)
Inventor
Wolfgang Stremmel
Original Assignee
Pat Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pat Gmbh filed Critical Pat Gmbh
Publication of PL1926499T3 publication Critical patent/PL1926499T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06805305T 2005-09-21 2006-09-18 Zastosowanie terapeutycznie aktywnych lipidów wraz ze sposobem wytwarzania swoistych dla narządu/tkanki terapeutycznie aktywnych lipidów PL1926499T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005045152A DE102005045152A1 (de) 2005-09-21 2005-09-21 Verwendung von therapeutisch wirksamen Lipiden nebst Verfahren zur Herstellung von Organ-/Gewebe-spezifischen therapeutisch wirksamen Lipiden
EP06805305.7A EP1926499B9 (de) 2005-09-21 2006-09-18 Verwendung von therapeutisch wirksamen lipiden nebst verfahren zur herstellung von organ-/gewebe- spezifischen therapeutisch wirksamen lipiden
PCT/DE2006/001651 WO2007033654A1 (de) 2005-09-21 2006-09-18 Verwendung von therapeutisch wirksamen lipiden nebst verfahren zur herstellung von organ-/gewebe- spezifischen therapeutisch wirksamen lipiden

Publications (1)

Publication Number Publication Date
PL1926499T3 true PL1926499T3 (pl) 2014-06-30

Family

ID=37460134

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06805305T PL1926499T3 (pl) 2005-09-21 2006-09-18 Zastosowanie terapeutycznie aktywnych lipidów wraz ze sposobem wytwarzania swoistych dla narządu/tkanki terapeutycznie aktywnych lipidów

Country Status (11)

Country Link
US (2) US8883426B2 (pl)
EP (1) EP1926499B9 (pl)
CN (2) CN101287499B (pl)
CY (1) CY1115038T1 (pl)
DE (1) DE102005045152A1 (pl)
DK (1) DK1926499T3 (pl)
ES (1) ES2458304T3 (pl)
PL (1) PL1926499T3 (pl)
PT (1) PT1926499E (pl)
SI (1) SI1926499T1 (pl)
WO (1) WO2007033654A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2923710A1 (en) * 2014-03-27 2015-09-30 Universitätsklinikum Heidelberg Bacterial phospholipase inhibitors as modulator of colonic bacterial flora
CN110840901A (zh) * 2019-12-12 2020-02-28 南京大学 溶血磷脂酰乙醇胺18:1在制备缓解、治疗炎症性肠病药物中的应用
CN112305120B (zh) * 2020-10-30 2022-02-08 河北医科大学第二医院 代谢物在动脉粥样硬化性脑梗死中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843474A (en) * 1995-10-11 1998-12-01 Reverse Transport Licensing & Consulting, Inc. Method of dialysis treatment, and dialysis apparatus related thereto
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US6677319B1 (en) * 1998-08-06 2004-01-13 Wolfgang Stremmel Phosphatidylcholine as medication with protective effect large intestinal mucosa
WO2001051003A2 (en) * 2000-01-10 2001-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
DE10249890A1 (de) * 2002-10-25 2004-05-13 Wieland, Heinrich, Prof. Dr. Gallensäurekonjugate und damit gebildete Partikel

Also Published As

Publication number Publication date
EP1926499A1 (de) 2008-06-04
US8883426B2 (en) 2014-11-11
HK1121689A1 (en) 2009-04-30
US20150038472A1 (en) 2015-02-05
CN103432589A (zh) 2013-12-11
DE102005045152A1 (de) 2007-03-22
CN101287499A (zh) 2008-10-15
SI1926499T1 (sl) 2014-05-30
CN101287499B (zh) 2013-04-03
CN103432589B (zh) 2015-04-29
ES2458304T3 (es) 2014-04-30
CY1115038T1 (el) 2016-12-14
EP1926499B1 (de) 2014-01-22
PT1926499E (pt) 2014-04-22
HK1188558A1 (en) 2014-05-09
EP1926499B9 (de) 2014-04-16
DK1926499T3 (da) 2014-04-14
US20080166401A1 (en) 2008-07-10
WO2007033654A1 (de) 2007-03-29

Similar Documents

Publication Publication Date Title
GB2441489B (en) Stylet apparatuses and methods of manufacture
ZA200803555B (en) Manufacture of esters
GB0718972D0 (en) Compounds and methods of making the compounds
TWI349334B (en) Dram structure and method of making the same
ZA200708932B (en) Manufacture of ferroalloys
EP1904014A4 (en) WOUND ASSOCIATION AND METHOD FOR ITS MANUFACTURE AND USE
IL182940A0 (en) Solid electrolyte and method of producing the same
EP1957145A4 (en) MICRONADEL ASSEMBLIES AND APPLICATION METHOD
GB0509845D0 (en) Preparation of therapeutic foam
TWI346826B (en) Bonding structure and method of fabricating the same
EP1967171A4 (en) SKIN PATCHES AND METHOD OF MANUFACTURE THEREOF
PL2091385T3 (pl) Miotły i sposoby wytwarzania mioteł
EP1919477A4 (en) METHOD FOR IMPROVING THE GRID OF GROWTH
PL1926499T3 (pl) Zastosowanie terapeutycznie aktywnych lipidów wraz ze sposobem wytwarzania swoistych dla narządu/tkanki terapeutycznie aktywnych lipidów
EP2099437A4 (en) POROUS KERATIN CONSTRUCT AND METHOD OF MANUFACTURING THEREOF
EP1755635A4 (en) TREATMENT OF INFLAMMATORY RESPIRATORY DISEASE
GB0500700D0 (en) Process for the manufacture of 2-alkyl-3-phenylpropionic acids and alcohols
GB2423583B (en) Manufacture of interactive surface
EP1951357A4 (en) MICRONADELANTS AND MANUFACTURING METHOD THEREFOR
EP1907438A4 (en) N-HYDROXYALKYLTRIMELLITIMIDESTER AND BIS- (TRIMELLITIMID) ESTERS AND THEIR MANUFACTURING PROCESS
GB0714776D0 (en) Play structure and accessories therefor
ZA200800590B (en) Method of improving wakefulness
IL176713A0 (en) Internal structure of mattress and the method to manufacture it
TWM300074U (en) Improved structure of chair chassis
TWI315902B (en) Method of fabricating interconnecting